DP
Congress trade
Sen. David Perdue (R-GA) sold $1K-$15K of Pfizer Inc. (PFE) stock
David Perdue, U.S. Senator (R-GA), disclosed a sale of Pfizer Inc. (PFE) stock worth $1K-$15K in a STOCK Act filing on Mar 5, 2018.
The trade happened on Feb 23, 2018, 10 days before it was made public.
PFE has moved -19.2% since the trade date, from $34.40 to $27.80 (Oct 2, 2026 close).
- Traded
- Feb 23, 2018
- Disclosed
- Mar 5, 2018
- Filing delay
- 10 days
- Price since
- -19.2%
- Source
- STOCK Act disclosure
Other trades in this disclosure (46)
- BuyUPS$50K-$100KMar 5, 2018
- BuyGLW$15K-$50KMar 5, 2018
- BuySU$15K-$50KMar 5, 2018
- BuySU$15K-$50KMar 5, 2018
- BuyUPS$15K-$50KMar 5, 2018
- BuyUPS$15K-$50KMar 5, 2018
- SellXOM$15K-$50KMar 5, 2018
- SellXOM$15K-$50KMar 5, 2018
- BuyAXTA$1K-$15KMar 5, 2018
- SellBAC$1K-$15KMar 5, 2018
- SellBAC$1K-$15KMar 5, 2018
- BuyCBS$1K-$15KMar 5, 2018
- SellCSCO$1K-$15KMar 5, 2018
- SellDISCA$1K-$15KMar 5, 2018
- BuyDVN$1K-$15KMar 5, 2018
- BuyDVN$1K-$15KMar 5, 2018
- BuyDVN$1K-$15KMar 5, 2018
- BuyDVN$1K-$15KMar 5, 2018
- BuyDVN$1K-$15KMar 5, 2018
- BuyFEYE$1K-$15KMar 5, 2018
More PFE insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.